Bellen Chemistry, established in 2007, originally focused on the design and development of hundreds of novel heterocycles. Over a number of years our innovative capabilities and reliable performance were gradually becoming more recognized in the marketplace, and our customers encouraged us to develop CRO/CDMO business with them.